Genetically modified IL2 bone-marrow-derived myeloid cells reprogram the glioma immunosuppressive tumor microenvironment
Cell Reports · 2023-08 · 42 (8) · 112891
DOI: 10.1016/j.celrep.2023.112891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023-08. Verfasst von Alessandro Canella und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Glioma, Interleukin-2, Myeloid Cells. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ian's Friends Foundation, Nationwide Children's Hospital.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
- Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
- Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
- Department of Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
- Department of Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA; Pelotonia Institute for Immuno-Oncology, The Ohio State University, Co…
- Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, USA.
Förderung
- Ian's Friends Foundation
- Nationwide Children's Hospital
Zitieren
APA
Canella, A., Nazzaro, M., Rajendran, S., Schmitt, C., Haffey, A., Nigita, G., Thomas, D., Lyberger, J. M., Behbehani, G. K., Amankulor, N. M., Mardis, E. R., Cripe, T. P., & Rajappa, P. (2023). Genetically modified IL2 bone-marrow-derived myeloid cells reprogram the glioma immunosuppressive tumor microenvironment. Cell Reports, 42(8), 112891. https://doi.org/10.1016/j.celrep.2023.112891
Vancouver
Canella A, Nazzaro M, Rajendran S, Schmitt C, Haffey A, Nigita G, et al. Genetically modified IL2 bone-marrow-derived myeloid cells reprogram the glioma immunosuppressive tumor microenvironment. Cell Reports. 2023;42(8):112891. doi:10.1016/j.celrep.2023.112891
BibTeX
@article{Canella2023,
author = {Canella, Alessandro and Nazzaro, Matthew and Rajendran, Sakthi and Schmitt, Claire and Haffey, Abigail and Nigita, Giovanni and Thomas, Diana and Lyberger, Justin M and Behbehani, Gregory K and Amankulor, Nduka M and Mardis, Elaine R and Cripe, Timothy P and Rajappa, Prajwal},
title = {Genetically modified IL2 bone-marrow-derived myeloid cells reprogram the glioma immunosuppressive tumor microenvironment},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {8},
pages = {112891},
doi = {10.1016/j.celrep.2023.112891}
}
EUVIMED